Suboxone Lawsuit – January 2025 Update

Suboxone, a two-drug medication commonly used to treat opioid addiction, has come under scrutiny as lawsuits against the manufacturer of the drug mount. Court documents indicate that the sublingual strips may put users at an increased risk of developing severe dental problems, including tooth decay, gum disease, and tooth loss. Thousands of lawsuits were recently consolidated into multidistrict litigation (MDL) in the Northern District of Ohio, with thousands of additional plaintiffs expected to come forward as litigation continues.

Suboxone Lawsuit Overview

Suboxone is a two-drug medication that has become increasingly popular since its debut in 2002. Previously available only as a dissolvable tablet, the prescription now comes in sublingual strips containing a 4:1 ratio of buprenorphine and naloxone. The medication is used to treat opioid addiction and has been touted for its quick efficacy and lower risk of dependency compared to other opioid addiction treatments such as methadone.  

The introduction of the fast-acting under-the-tongue strip in 2012 propelled the drug’s use. Unfortunately, the sublingual strip can cause severe dental issues, according to an increasing number of lawsuits against the manufacturer. Despite concerns, there were no warnings about the risk of these problems until 2022, nearly a decade after the initial reports were filed. 

Dental problems reportedly linked to Suboxone use: 

• Severe tooth decay 
• Tooth loss and extraction 
• Cracked teeth and increase in cavities 
• Injuries to the gum and teeth 
• Oral infections 
• Dental caries (such as loss of enamel, dentine, etc.) 

These problems have led to the need for Suboxone users to get root canals, crowns, crown replacements, and other expensive dental procedures. Allegations against the manufacturer of Suboxone, Indivior, Inc., include that the company knew about the risk of severe tooth decay associated with the drug and failed to warn prescribing doctors and patients, prioritizing profits over consumer safety. Individuals who have used Suboxone and suffered adverse reactions may be eligible to file a lawsuit or join the multidistrict litigation pending in federal court.  

It is believed that Invidivor, a specialty pharmaceutical company focused on opioid dependency drugs, may have rushed the sublingual film to market, ignoring adverse event reports to avoid potential competition. Further allegations include that the manufacturer may have failed to complete their due diligence when it comes to warning consumers about the potential for severe dental issues or even intentionally hid the risks to prevent a slowdown from the U.S. Food and Drug Administration. Individuals adversely affected by the drug are encouraged to seek legal counsel. Depending on the circumstances, they may be eligible for compensation related to the psychological and emotional distress caused by the drug’s side effects and the financial burden related to costly dental treatments.  

Suboxone Lawsuit for Tooth Decay – 2025 Updates

January 17, 2025: Dental Damages Lead to Woman Filing New Suboxone Lawsuit 

A woman in New Mexico has filed a Suboxone lawsuit after its sublingual films caused permanent damage to her teeth, requiring substantial dental work. Gayle Ortega filed her lawsuit against Indivior, Aquestive Therapeutics, and Monosol Rx, who all made or sold versions of buprenorphine-naloxone strips. Ortega was prescribed Suboxone films after she became addicted to painkillers prescribed by her doctor. Her complaint said she was never warned of the dangerous dental risks from Suboxone films. Her lawsuit was filed as part of the multidistrict litigation against Suboxone film manufacturers (Suboxone (Buprenorphine/Naloxone) Film Product Liability Litigation). She is seeking multiple damages for her dental injuries, pain and suffering, loss of income, and other injuries.

January 8, 2025: Suboxone Multidistrict Lawsuit Will Proceed; Cases Are Not Dismissed

The consolidated litigation against Suboxone film manufacturer Indivior will move forward. Indivior had asked for all of the dental injury lawsuits in the multidistrict litigation (MDL) to be dismissed. This would have been bad news for many people harmed by Suboxone films. However, in an order and opinion issued by Judge J. Philip Calabrese and Magistrate Judge Jennifer Dowdell Armstrong, the Suboxone litigation will move forward throughout 2025. Although some specific allegations against Indivior have been dismissed, the bulk of the legal complaint against them was allowed by the courts. This is great news for people who suffered severe dental issues due to Suboxone films. The next case conference will be held January 14, 2025, where plaintiffs will learn more about the path forward for their cases and potential future settlements.

January 2, 2025: 38 More People With Dental Injuries Join the Consolidated Litigation Against Suboxone

From December to January 2, 2025, 38 more people who were injured by Suboxone sublingual films joined the multidistrict litigation (MDL) against the drug’s manufacturer, Indivior. As of January 2, there are 754 pending lawsuits in the Suboxone MDL, which is similar to a class action lawsuit against the makers of Suboxone films. These films have caused severe tooth decay and dental injuries in many patients. As the MDL progresses throughout 2025, people harmed by suboxone could receive payments through settlements. This assumes Indivior’s motion to dismiss the lawsuits is unsuccessful.

About the Suboxone Lawsuit:

What is the Suboxone Lawsuit About?

The Suboxone lawsuit is based on thousands of claims that the medication increases a person’s risk of developing serious dental issues, including tooth erosion and decay. Manufactured by Indivior, Inc. (formerly known as Reckitt Benckiser Pharmaceuticals, Inc.), the drug was originally available in a dissolvable tablet before being switched to a sublingual film with a more acidic ingredient. Litigation alleges that the manufacturer switched to oral film to extend their monopoly and prevent generic manufacturers from being able to bring a lower-cost pill to market.  

The film contains a 4:1 ratio of buprenorphine hydrochloride and naloxone hydrochloride dihydrate. Buprenorphine acts as a substitute for opioids and is known to help with withdrawal symptoms. In January 2022, the FDA issued warnings about the potential for buprenorphine to cause serious dental problems. The drug, in sublingual film form, had been on the market for ten years without any warning about the effects it could have on teeth or gums. In June 2022, a warning was finally added to the label.  

Accusations against Indivior include that the company knew or should have known about the risk to the user’s dental health and failed to warn medical providers and consumers, putting profits over patients. Additionally, lawsuits allege that the company promoted the film as a safer, less abusable alternative to other opioid treatments. It is believed that the company obtained billions of dollars in revenue.  

Is the Suboxone Lawsuit a Class Action or MDL? 

While frequently used interchangeably, class action lawsuits and multidistrict litigation refer to two distinct types of legal actions. Class action lawsuits allow one or more plaintiffs to represent a larger group with similar claims. They can be filed in state or federal court. Multidistrict litigation (MDL) involves the consolidation of multiple lawsuits into one federal court to promote efficiency. Unlike a class action lawsuit, plaintiffs in an MDL maintain their individual status throughout the litigation.  

Lawsuits have been filed nationwide against the manufacturer of Suboxone, alleging the medication causes severe dental issues. On February 2, 2024, the Judicial Panel on Multidistrict Litigation consolidated multiple lawsuits into an MDL for Suboxone lawsuits in an effort to streamline litigation.   

The manufacturer of Suboxone, however, was previously the subject of a class action lawsuit involving the violation of antitrust laws. The litigation alleged that the pharmaceutical company strategized to prevent generic drug companies from offering a lower-priced version of the medication. The class action was eventually settled for a multi-million dollar payout. 

What is Suboxone and How Does It Work?

Suboxone is a two-drug medication used to treat opioid addiction in adults and adolescents over the age of 15. It is generally used as part of a comprehensive treatment program along with counseling. It is available by prescription and administered as a dissolvable film (sublingual or buccal), pill, or implant. The film tends to allow for easier dose tapering, but many find the tablets to be more discreet. 

The medication combines buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist). It was frequently touted as a safer, less abusable opioid treatment that could help reduce withdrawal symptoms while preventing misuse-induced euphoria.  

Suboxone mechanism of action and role in Medication-Assisted Treatment (MAT):  

• Buprenorphine: Mimics opioid effects without euphoria and reduces withdrawal symptoms and cravings. 
• Naloxone: Facilitates recovery by blocking opioid receptors to prevent misuse-induced euphoria. 

Effects from Suboxone typically last from 24 to 36 hours, with common side effects being headache, nausea, constipation, and withdrawal symptoms.  

Suboxone Sublingual Film and Its Role in the Lawsuit

Since 2012, Suboxone (buprenorphine and naloxone) has been prescribed in sublingual film to treat opioid addiction in adults. It is often considered an integral component of comprehensive treatment programs that include counseling and behavioral therapy. For maximum absorption, the sublingual film should be placed under the tongue and allowed to dissolve completely. Chewing the film too early may reduce its effectiveness or lead to withdrawal symptoms.  

Prior to the introduction of the sublingual film, the drug had been prescribed as a dissolvable tablet. The film contains a much higher acidity (pH 3.4), which has been found to lead to enamel erosion, gum disease, and oral infections with prolonged use. Additionally, Suboxone users report experiencing reduced saliva production, which may exacerbate dental issues by reducing the mouth’s natural protective barrier against acidity.  

In January 2022, the FDA issued a warning to consumers about the potential for adverse dental effects linked to buprenorphine after numerous complaints about the issue, including patients reporting the loss of teeth. Until this point, the medication did not contain any warnings related to the risk of enamel erosion, oral infections, or other dental problems. It is alleged that the manufacturer failed to adequately disclose the potential dental risks associated with the use of Suboxone.  

Suboxone Sublingual Film – Active and Inactive Ingredients

Suboxone, an orange, rectangular soluble film, has a number of active and inactive ingredients. The ingredients, in combination with how the drug is administered, may cause serious side effects, including adverse dental issues.  

Active ingredients in Suboxone: 

• Buprenorphine Hydrochloride: Acts as a partial opioid agonist, helps manage opioid withdrawal symptoms and cravings, and mimics the effects of opioids without causing the same level of euphoria. 
• Naloxone Hydrochloride Dihydrate: Acts as an opioid antagonist, blocks opioid receptors in the brain, reverses the effects of opioids, and can precipitate withdrawal if misused by injection.

Inactive ingredients in Suboxone: 

• Acesulfame Potassium: Artificial sweetener used to improve taste. 
• Citric Acid: Used as a flavoring agent and helps maintain acidity for stability. 
• Maltitol: Sugar alcohol that is used as a sweetener, adding bulk to the formulation. 
• Hypromellose: Polymer that is used as a thickening agent and enhances film formation. 
• Polyethylene Oxide: Polymer that is used as a binder and aids in film consistency. 
• Sodium Citrate: Used as a buffer and helps maintain pH balance. 
• Natural Lime Flavor 3000180: Adds flavor to improve palatability. 
• Sunset Yellow FCF: Synthetic food coloring that provides an orange color to the film. 

Each film is imprinted with a logo indicating its dosage strength, i.e., “N2” (2 mg), “N4” (4mg), “N8” (8mg), and “N12” (12mg). Each pack is labeled with specific Australian Register Numbers (AUST R) corresponding to different strengths. It is recommended that the medication is stored in its original packaging at temperatures below 25°C to protect from light and moisture exposure.  

Suboxone Dental Injuries and Health Risks

The use of Suboxone administered through a sublingual film has been linked to dental injuries and adverse health conditions, including tooth decay, oral infections, gum disease, and more. The medication’s high acidic pH is believed to exacerbate enamel erosion and increase a person’s susceptibility to tooth decay. Additionally, opioids are known to cause dry mouth or xerostomia, a condition that reduces saliva production, hindering the body’s natural ability to neutralize acid and repair enamel, as well as increasing the risk of dental caries.  

According to a research letter published in the Journal of the American Medical Association (JAMA):  

• Out of every 1,000 Suboxone users, approximately 21.6 will experience a dental adverse event each year. 
• Out of every 1,000 Suboxone users, around 8.2 will develop dental caries or experience tooth loss each year. 

Suboxone users may experience an increase in cravings for sugary foods and beverages, enhancing the risk for tooth decay, particularly when combined with dry mouth conditions. Because holding the film under the tongue is the most effective way to absorb it, users may have prolonged acidic exposure, further exacerbating enamel erosion. Finally, any normal neglect of oral hygiene resulting from lifestyle factors may raise the already present risk of dental decay. 

Rotted, Cracked, and Broken Teeth 

One of the most prevalent adverse health conditions reported by Suboxone users is rotted, cracked, and broken teeth. The acidic nature of the sublingual film is believed to increase a person’s risk of tooth decay. Users are required to hold the film under the tongue until it is completely dissolved, generally taking several minutes and resulting in prolonged acidic exposure. Tragically, many users had to have permanent teeth removed as a result of the decay. 

Oral Infections 

Another common complaint of Suboxone users is repeated oral infections. Dental infections are costly to repair and can lead to additional problems, including root canals, dental surgery, and extraction. 

Dry Mouth (Xerostomia) 

The properties of Suboxone may also cause Dry Mouth or xerostomia. The condition causes a reduction in saliva in the mouth, reducing the body’s natural ability to protect the enamel of the teeth and counteract acidity. A lack of saliva can increase the amount of bacteria in the mouth, leading to tooth decay and other health conditions.  

Other Dental Injuries and Health Issues 

Suboxone patients have reported other dangerous dental injuries and health conditions such as gum disease, enamel erosion, and jaw problems. Treatment options for these issues are cost-prohibitive in many cases and may require extensive out-of-pocket payments. Common repairs include cavity fillings, crowns, crown replacements, and tooth extractions.  

Research Links Suboxone Use to Tooth Decay

There have been several studies conducted on side effects related to Suboxone, particularly the potential for the medication to cause tooth decay and other dental conditions. As a result of over 300 reported adverse events, the FDA issued a warning to consumers about the risk of dental issues caused by buprenorphine. The warning, however, was issued a decade after the sublingual film was marketed to consumers. Prior to the FDA’s findings, the medication did not list any warning for the potential of serious dental side effects related to its use.  

According to “Sublingual Buprenorphine and Dental Problems: A Case Series,” published in The Primary Care Companion for CNS Disorders, on average, each person had: 

• Approximately 5 cavities, 4 fillings, and 2 cracked teeth. 
• Needed 1 crown, 1 root canal, and 1 tooth pulled. 

Over half (54.5%) of the people reported tooth pain, and 36.4% said they had low saliva buffering, meaning their saliva was less effective at neutralizing acid. Low saliva buffering is linked with a higher risk of cavities and other dental problems. Less than 10% had high saliva buffering. 

The Research Letter published in JAMA, studied over 20,000 new users of sublingual buprenorphine/naloxone, 5,000 users of transdermal buprenorphine, and 6,600 users of oral naltrexone.   

Their findings indicated: 

• There was a higher incidence of dental problems with sublingual buprenorphine/naloxone (21.6 per 1000 person-years). 
• There was a lower incidence with transdermal buprenorphine (12.2 per 1000 person-years) and oral naltrexone (10.9 per 1000 person-years). 
• Sublingual buprenorphine/naloxone users have a 42% higher risk of dental issues compared to transdermal buprenorphine users. 
• Sublingual buprenorphine/naloxone users have a 67% higher risk compared to oral naltrexone users. 
• The incidence of dental caries was 8.2 per 1000 person-years for sublingual buprenorphine/naloxone users, 3.5 for transdermal buprenorphine users, and 3.8 for oral naltrexone users.  

FDA Issues Warning on Suboxone Use and Tooth Decay

On January 12, 2022, after over 300 reports of adverse health reports received by users nationwide, the FDA issued a warning to consumers about the potential for an increased risk of dental problems associated with buprenorphine medications that dissolve in the mouth and are used for opioid use disorder.  

Dental health issues were reported in some patients who had no prior history of dental problems. Of the 305 reported dental problems, 131 were classified as serious, with the average age of the patient being 42, although some patients were as young as 18. Dental problems began as early as 2 weeks after starting treatment, with a median diagnosis time of 2 years.  

Issues reported to the FDA included: 

• Tooth decay 
• Cavities 
• Oral infections 
• Loss of teeth 

Treatments for these conditions included tooth extraction/removal, root canals, dental surgery, crowns, and implants.  

As a result of these reports, the FDA made several recommendations and requirements, including updated prescribing information, the addition of a warning about dental risks, and the inclusion of health maintenance strategies. The FDA recommended that individuals using buprenorphine medications engage in regular dental checkups and inform their providers about all medications they are taking. Additionally, preventative measures such as swishing water around after the medication has dissolved and waiting at least an hour before brushing are recommended.   

Strategies recommended to healthcare providers included assessing the patient’s oral health history and referring patients to dental care services before prescribing the medication. During treatment, providers were suggested to counsel patients on potential dental risks and encourage regular checkups. Dentists should perform baseline dental evaluations and establish preventative plans for patients.  

Suboxone Manufacturer: Indivior Inc.

Suboxone manufacturer Indivior, Inc. was founded in 1994 as a subset of Reckitt Benckiser but became independent in 2014. Its headquarters are in Richmond, Virginia. The company has expanded through strategic acquisitions such as Opiant Pharmaceuticals in November 2022.  

Indivior focuses on buprenorphine-containing medications such as Suboxone tablets, which were introduced in 2002 for the treatment of opioid use disorder (OUD). Initially, the company faced little competition, transitioning to sublingual films when the trademarks on the tablets expired. It also manufactures Subutex, which only contains buprenorphine, and Sublocade, an extended-release injectable for OUD treatment.  

It is believed that Indivior managed competition and maintained market control by moving to new formulations and introducing new delivery methods as their patents expired. The company settled multiple multi-million dollar lawsuits that alleged they violated antitrust laws related to these issues.  

Deceptive Marketing Practices Regarding Safety of Suboxone

In addition to lawsuits related to the failure to warn consumers about the potential for adverse dental conditions related to the use of Suboxone, the manufacturer has faced legal action dating back to 2012 for its alleged deceptive marketing practices.  

In July 2019, Indivior pled guilty to felony charges related to these claims and paid $600 million for criminal and civil liability. Individor’s predecessor, Reckitt Benckiser, resolved similar charges with a $1.4 billion settlement with the U.S. Department of Justice.  

In October 2019, a $700 million settlement was reached with New York and five other states for improper marketing. These claims included that the drug was safer and less addictive than other products, false data was sent claiming the film had the lowest pediatric exposure rate, the promotion of the drug for non-medically accepted uses, and that it was less subject to abuse and diversion than similar medications.   

Further allegations include that the manufacturer falsely claimed the tablets were discontinued out of safety concerns and that they strategically delayed the entry of generic competition to control Suboxone pricing.  

Who Qualifies to File a Suboxone Lawsuit?

In order to file a Suboxone lawsuit, you must meet certain qualifications. To determine whether you meet the eligibility requirements, it is strongly recommended that you speak with an attorney as soon as possible.

Eligibility requirements for a Suboxone lawsuit include:  

• You were prescribed Suboxone FILMS before January 2022.
• You used Suboxone for at least six months before injuries occurred.
• You experienced tooth loss or required tooth extractions, .
• You had routine dental care prior to taking Suboxone.
• You were not warned about the risk of dental injuries while taking Suboxone.
• You never used methamphetamine.

Additionally, your claim must be filed within the statute of limitations for product liability cases. It is strongly recommended that you consult with a qualified Suboxone tooth decay lawyer to determine if your claim is still valid and if an extension of time is possible.

Evidence to Gather Before Filing a Suboxone Lawsuit:

Prior to filing a Suboxone lawsuit, it is imperative to gather the necessary evidence to substantiate your case. Some of the most important things to consider and collect are medical records and dental records regarding your Suboxone use and subsequent injuries. 

Evidence that may help to prove your case: 

• Medical records  
• Paperwork from your doctor and dentist appointments 
• Proof of surgeries or procedures 
• Any billing documents 
• Dental x-rays and imaging reports 
• Records of dental treatments 
• Proof of Suboxone prescriptions 
• Pharmacy records 
• Detailed personal statements regarding dental issues 
• Testimonies from family members or caregivers 
• Insurance claims and reimbursements 
• Records related to out-of-pocket expenses 
• Statements from dental and medical experts linking Suboxone to dental issues 
• Communications with healthcare providers discussing the risks and side effects of Suboxone 
• Before and after photos showing the progression of dental damage 
• Any documents that show a clear connection between Indivior’s negligence, your injuries, and your financial losses.  

Recoverable Damages in a Suboxone Lawsuit

Individuals who meet the qualifications for a Suboxone lawsuit may be entitled to compensation. Recoverable damages may include economic and non-economic losses. To determine the value of your claim, you should speak with an attorney as soon as possible.  

Economic damages in a Suboxone lawsuit may include recovery for: 

• Medical bills: Costs of dental treatments, surgeries, procedures, follow-up care, and maintenance. 
• Lost wages: Income lost due to time off from work for treatments and recovery. 
• Loss of future earning potential.  

Non-economic damages in a Suboxone lawsuit may include recovery for: 

• Pain and suffering 
• Physical and emotional distress 
• Chronic pain, difficulty eating or speaking 
• Embarrassment and social anxiety

Emotional distress includes the psychological impact of dental injuries, any anxiety, depression, and reduced quality of life experienced as a result of the dental conditions, lifestyle disruptions, and any impact on daily activities and social interactions. 

How to File a Suboxone Lawsuit

To file a Suboxone lawsuit, you need to file certain steps that ensure your eligibility and that all legal requirements are met. It is important to understand that all Suboxone lawsuit cases are subject to a state-specific statute of limitations. An attorney can help ensure that your case is filed timely. 

Step-by-step guide for filing a Suboxone lawsuit: 

1. Obtain a case evaluation: During your initial case evaluation, an attorney will help to ensure the viability of your case. Prior to your consultation, it is important to identify your symptoms and document evidence of your injuries, including all instances of tooth decay and any related dental issues. You should also gather medical records, dental records, and Suboxone prescription history. 
2. Legal preparation: The attorney you hire should be well-versed in product liability cases. They can help ensure that you collect the necessary evidence to help prove your case, including your full medical and dental history with all treatments and diagnoses related to your injuries. You will also want to secure any communications with your healthcare provider detailing Suboxone and its side effects. Finally, you will need to collect any receipts or bills for dental treatments related to tooth decay. An attorney can help you identify potential witnesses such as healthcare providers, family members, or friends who can attest to your Suboxone use and subsequent dental issues. 
3. Filing the lawsuit: Through your attorney, you will draft a complaint outlining the factors of your case and drawing the connection between your use of Suboxone and your tooth decay, as well as detailing the damages you are seeking. Your attorney will ensure that the complaint is filed in the appropriate court and that the document is formally served on all potential defendants, primarily the manufacturer of Suboxone. 
4. Discovery phase: Once the case is filed, it will enter into the discovery phase. The discovery phase allows for an exchange of information and documents between the parties. During this phase, there will likely be witness depositions and expert testimony. 
5. Pre-trial motions and settlement negotiations: Throughout the litigation process, each side may file pre-trial motions to try to resolve certain issues before trial. The motions may include attempts to dismiss the case or to compel the other side to produce evidence. The parties may also enter into settlement negotiations in an attempt to avoid going to trial. 
6. Trial: If a fair settlement cannot be reached, both sides prepare for trial. Trial preparation includes finalizing arguments, preparing witnesses, and organizing evidence. During the trial, the case is presented in court, and each side argues its case before a judge or jury.
7. Post-trial: If you win the case, the court will determine the amount of damages to be awarded. If you lose, your lawyer may file an appeal if there are grounds to do so. If you win and the verdict is not appealed, the defendant will be ordered to pay the damages awarded by the court. 

Suboxone Lawsuit Statute of Limitations and Filing Deadlines

All Suboxone lawsuits are subject to state-specific statutes of limitations, which are legal timelines within which cases must be filed. In general, the deadline for filing a Suboxone lawsuit with a two-year statute of limitations is June 14, 2024, due to the warning label changes that were made in June 2022. Plaintiffs’ lawyers were required to file a master MDL list by this date.  

For Suboxone lawsuits with a three-year statute of limitations, the deadline for filing will be June 2025. It is not expected that many cases will settle prior to the passing of the three-year statute of limitations. The Discovery Rule, which can extend a statute of limitations beyond the standard two or three-year timeframe, applies from the time a person discovers their injury and knows it was caused by negligence.  

Failure to file within the statute of limitations can result in you being barred from filing a lawsuit against Indivior or another defendant. A lawyer may assist in entering a tolling agreement, which can suspend the statute of limitations and protect your ability to file a claim. This helps to accommodate any delays that may occur in attempting to secure medical and dental records.  

Suboxone Settlement and Payout Amounts

Suboxone settlement and payout amounts are expected to range between $50,000 and $150,000, depending on the individual circumstances of the case. Several factors may influence the value of a person’s case, including the severity of dental damage, treatment costs, and emotional suffering. 

Factors that may influence the settlement value of a Suboxone claim: 

• Past Medical Bills: Costs related to diagnosing and treating tooth decay, including dental visits, procedures, medications, and hospital stays.
• Future Medical Costs: Estimate of ongoing or anticipated treatments and care for tooth decay and related complications.
• Lost Income: Wages lost due to time off work for medical appointments and recovery.
• Future Earning Capacity: Impact on ability to work in the future, including potential career changes or diminished earning capacity.
• Physical Pain: Discomfort caused by tooth decay and related treatments.
• Emotional Distress: Psychological impact, including anxiety, depression, and loss of enjoyment of life.
• Disability: Long-term or permanent disabilities resulting from tooth decay and its treatment.
• Disfigurement: Permanent changes to appearance, such as missing teeth or dental implants.
• Loss of Consortium and Impact on Relationships: Effects on relationships with a spouse, children, and other family members, including loss of companionship, support, and intimacy.
• Punitive Damages and Manufacturer’s Conduct: Evaluation of whether the manufacturer acted with gross negligence, malice, or intentional misconduct.
• Comparative Fault and Shared Responsibility: Assessment of any shared fault in the case, compensation may be reduced proportionately if partially responsible for the condition.

Laws of the state where the lawsuit is filed can impact compensation, including caps on certain types of damages. Some plaintiff-friendly jurisdictions may result in higher compensation. It is important to know that the arrangement with your attorney is typically a percentage of the compensation awarded. Other legal costs include filing fees, expert witness fees, and court costs. To protect your settlement, you will want to practice good dental hygiene and attend dentist appointments. Be sure to address all dental emergencies promptly.  

Contact a Suboxone Lawyer

If you were prescribed Suboxone prior to 2022 and suffered adverse dental issues, you may be entitled to compensation. It is imperative to contact a lawyer as soon as possible to determine whether you have a valid case. At King Law, we have extensive experience working with individuals in product liability cases, including those against drug manufacturers. Contact our office today to schedule a free, no-obligation consultation.  

Frequently Asked Questions (FAQs)